117 related articles for article (PubMed ID: 27509977)
1. Combined Genotype Analyses of Precursor miRNA196a2 and 499a Variants with Hepatic and Renal Cancer Susceptibility a Preliminary Study.
Toraih EA; Fawz MS; Elgazzaz MG; Hussein MH; Shehata RH; Daoud HG
Asian Pac J Cancer Prev; 2016; 17(7):3369-75. PubMed ID: 27509977
[TBL] [Abstract][Full Text] [Related]
2. Precursor miR-499a Variant but not miR-196a2 is Associated with Rheumatoid Arthritis Susceptibility in an Egyptian Population.
Toraih EA; Ismail NM; Toraih AA; Hussein MH; Fawzy MS
Mol Diagn Ther; 2016 Jun; 20(3):279-95. PubMed ID: 27002721
[TBL] [Abstract][Full Text] [Related]
3. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
[TBL] [Abstract][Full Text] [Related]
4. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Ulger Y
J Viral Hepat; 2011 Jul; 18(7):e399-407. PubMed ID: 21692953
[TBL] [Abstract][Full Text] [Related]
5. Variants of MicroRNA Genes: Gender-Specific Associations with Multiple Sclerosis Risk and Severity.
Kiselev I; Bashinskaya V; Kulakova O; Baulina N; Popova E; Boyko A; Favorova O
Int J Mol Sci; 2015 Aug; 16(8):20067-81. PubMed ID: 26305248
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma.
Qiu GP; Liu J
Genet Test Mol Biomarkers; 2016 Oct; 20(10):579-586. PubMed ID: 27525669
[TBL] [Abstract][Full Text] [Related]
7. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population.
Wang XH; Wang FR; Tang YF; Zou HZ; Zhao YQ
Genet Mol Res; 2014 Jul; 13(3):5048-54. PubMed ID: 25061729
[TBL] [Abstract][Full Text] [Related]
8. Genetic variations in microRNAs and the risk and survival of renal cell cancer.
Du M; Lu D; Wang Q; Chu H; Tong N; Pan X; Qin C; Yin C; Wang M; Zhang Z
Carcinogenesis; 2014 Jul; 35(7):1629-35. PubMed ID: 24681820
[TBL] [Abstract][Full Text] [Related]
9. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
10. miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease.
Sung JH; Kim SH; Yang WI; Kim WJ; Moon JY; Kim IJ; Cha DH; Cho SY; Kim JO; Kim KA; Kim OJ; Lim SW; Kim NK
Mol Med Rep; 2016 Sep; 14(3):2328-42. PubMed ID: 27430349
[TBL] [Abstract][Full Text] [Related]
11. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population.
Ahn DH; Rah H; Choi YK; Jeon YJ; Min KT; Kwack K; Hong SP; Hwang SG; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E39-51. PubMed ID: 23001871
[TBL] [Abstract][Full Text] [Related]
12. Single Nucleotide Polymorphisms in
Bei C; Liu S; Yu X; Qiu M; Tang B; Liao W; He S; Yu H
Biomed Res Int; 2018; 2018():1540201. PubMed ID: 30662901
[TBL] [Abstract][Full Text] [Related]
13. Genetic variation in the microRNA-499 gene and hepatocellular carcinoma risk in a Turkish population: lack of any association in a case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Üsküdar O
Asian Pac J Cancer Prev; 2011; 12(11):3107-12. PubMed ID: 22393998
[TBL] [Abstract][Full Text] [Related]
14. miR-499A>G rs3746444 and miR-146aG>C expression and hepatocellular carcinoma risk in the Chinese population.
Shan YF; Huang YH; Chen ZK; Huang KT; Zhou MT; Shi HQ; Song QT; Yu ZP; Deng AM; Zhang QY
Genet Mol Res; 2013 Nov; 12(4):5365-71. PubMed ID: 24301908
[TBL] [Abstract][Full Text] [Related]
15. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
16. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
Huang Z; Lu Z; Tian J; Wang G; Gao Z
Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
[TBL] [Abstract][Full Text] [Related]
17. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
18. Single nucleotide polymorphism rs3746444 in miR‑499a affects susceptibility to non‑small cell lung carcinoma by regulating the expression of CD200.
Ge N; Mao C; Yang Q; Han B; Wang Y; Xu L; Yang X; Jiao W; Li C
Int J Mol Med; 2019 May; 43(5):2221-2229. PubMed ID: 30864695
[TBL] [Abstract][Full Text] [Related]
19. A functional polymorphism in MIR196A2 is associated with risk and prognosis of gastric cancer.
Wang S; Tao G; Wu D; Zhu H; Gao Y; Tan Y; Wang M; Gong W; Zhou Y; Zhou J; Zhang Z
Mol Carcinog; 2013 Nov; 52 Suppl 1():E87-95. PubMed ID: 23423813
[TBL] [Abstract][Full Text] [Related]
20. No association of pre-microRNA-146a rs2910164 polymorphism and risk of hepatocellular carcinoma development in Turkish population: a case-control study.
Akkız H; Bayram S; Bekar A; Akgöllü E; Usküdar O; Sandıkçı M
Gene; 2011 Oct; 486(1-2):104-9. PubMed ID: 21807077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
